Archives of Clinical Infectious Diseases
Infectious Diseases and Tropical Medicine Research Center, SBUMS
Authors
Infective endocarditis is one of the most important complications of injection drug use, which is associated with significant mortality and morbidity. The aim of this study was to evaluate the influence of vegetation size and localization on outcome and in-hospital mortality of infective endocarditis.
A total of 34 patients were admitted to a university hospital in a four-year period and analyzed prospectively. Injection drug users were defined as patients who had injected drugs intravenously within the past 3 months before admission. The diagnosis of infective endocarditis was made on the basis of modified Dukes criteria.
Totally, 38 episodes of endocarditis in 34 patients were identified. Patients were all male with the mean (standard deviation) age of 30.47.1 years. The affected valves were as follow: tricuspid valve in 26 cases (74.3%), mitral valve in 4 (11.4%), mitral and tricuspid valve in 4 (11.4%), and mitral and aortic valve in 1 (2.9%). The vegetation size was 10mm or less in 12 cases (34.29%), and more than 10mm in the remaining 23 cases (65.71%). Eight patients (21.1%) underwent surgery, however, unfortunately, nine (23.7%) died. Vegetations sized more than 10mm (p<0.033), involvement of the left-sided valves (p<0.012), and presence of more than one vegetation on TTE or TEE (p<0.05) were associated with higher probability of death.
In contrast to some earlier studies which concluded that vegetations larger than 20mm are associated with higher mortality, our results revealed that the mortality rate increases even with smaller vegetations. In addition, the number and the location of vegetations also could affect the prognosis. Therefore, lower threshold for surgical interventions should be applied in patients with vegetations larger than 10mm.
© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Soudbakhsh A, Hagiabdolbaghi M, Bagherian H, Yussefnejad O. Comparing Clinical and Laboratory Findings of Infective Endocarditis Among Intravenous Drug Users and Non-Drug Users. Arch Clin Infect Dis. 2007;2(4):. doi:
Heydari B, Karimzadeh I, Khalili H, Shojaei E, Ebrahimi A. Infective endocarditis; report from a main referral teaching hospital in Iran. Iran J Pharm Res. 2017;16(1):e124897. doi: https://doi.org/10.22037/ijpr.2017.1956
Alizadehasl A, Azarfarin R, Parvizi R, Sepasi F, Ghaffari S. SURGICAL MANAGEMENT OF ACTIVE INFECTIVE ENDOCARDITIS DURING 1996-06 IN TABRIZ, NORTHWESTERN IRAN. Int Cardiovasc Res J. 2018;1(3):e79413. doi:
Moradnejad P, Ghadrdoost B, Sadeghpour A, Maleki M, Pasha H, et al. Causative Microorganisms in Infective Endocarditis: Prospective Data from the Iranian Registry of Infective Endocarditis (IRIE). Int Cardiovasc Res J. 2022;16(2):e121998. doi:
Sadeghpour A, Boudagh S, Ghadrdoost B, Futuhi F, Alizadehasl A, et al. Acute Kidney Injury After Nephrotoxic Antibiotic Therapy in Patients with Infective Endocarditis. Arch Clin Infect Dis. 2019;14(5):e87617. doi: https://doi.org/10.5812/archcid.87617
More by these authors
Last Update: 1 month ago
Last Update: 1 month ago
Last Update: 1 month ago
Last Update: 5 days ago
Last Update: 1 day ago
Last Update: 2 days ago
